Developing fast non-expansive cancer detection from one drop of blood. Using micro-MRNA as the markers.

Dagan MD is a premier practice offering facial plastic and reconstructive, non-facial cosmetic procedures, ENT services, a sinus and allergy center and a hearing and balance center in midtown Manhattan. We offer the convenience of a local medical office, flexible hours and prompt appointment scheduling. Our practice features state-of-the-art treatments like the Balloon Sinuplasty, the latest breakthrough in long lasting relief from sinus symptoms to facial rejuvenation and makeovers as well as the latest in medical technology for the treatment of hearing and balance. see: www.daganmd.com

Founder and owner, President and CEO

Member of the Board for the Public Company Allium and member of the Board of its subsidieris IBI and Guardia.

Started as EndoGun, Ltd. A Uro-Gynecology Company, developed a stapling device for connecting support mashes to soft tissue. Received FDA and CE mark approvals within one year since the investment of $1.5 Millions, funding led by Dr. Dagan. In 2010 changed name to Israeli Biomedical Inovations, Ltd. (IBI) following an investment of $12.5 million

BlueMSO is a Healthcare Investment and Advisory Group. We are investing and / or advising multiple healthcare practices on accelerating their customer acquisition and profitability to position them for rapid growth and / or mergers and acquisitions. We have developed new digital strategies and tactics to help independent and small practices increase their patient acquisition and profitability by 10% to 33% resulting in substantial increases in their valuation.

Founder and EX. Chairman of the Board of this new venture dedicated to develop, manufacture and sell a new category of Laser Printers-the SmartPrint, which will reduce cost per print, will increase process uptime and will enable additional printing capabilities, beyond date & code. These laser printers are highly desired in the flexible film food, pharmaceutical and general goods automated packaging business.

The Company’s first product is the VaricureTM, a compact and portable device which facilitates localized cooling of the testicular area with the aim to obviate male infertility due to poor semen quality. MediTemp's unique proprietary technology will potentially serve an estimated 800,000 infertile men due to Varicoceles. VaricureTM will offer these men and their spouses a conservative, safe, economic and effective first-line therapy option to restore male fertility, before undergoing invasive, costly assisted-reproduction procedures.Male infertility is defined as an abnormality in sperm production, function or delivery that impedes a couple from establishing a pregnancy. Varicoceles, defined as abnormally dilated scrotal veins, are present in 15% of the normal male population and in approximately 42% of men presenting with infertility[1]. The preponderance of experimental data from clinical and animal models demonstrates an adverse effect of Varicoceles on spermatogenesis. Venous reflux and testicular temperature elevation appear to play important roles in Varicoceles-induced testicular dysfunction[1].[1] Report on varicocele and infertility, The Practice Committee of the American Society for Reproductive Medicine, Fertility and Sterility_ Vol. 86, Suppl 4, November 2006

ALFA RHYTHM was established in 2013, with the vision of affecting the brain's activity through triggering a variety of brain wave frequencies. The Company developed a BioMedical device that emits a range of electric pulses, stimulating the brain to imitate the current frequency at work. When compared to standard known transcranial magnetic stimulation devices, substantial advantages merit it being a multi-purpose self-operated revolutionary approach for mental stimulation. Alongside psychological and health oriented issues such as depression and ADHD, bolstered mental function and creativity provides the user with alertness, a sense of tranquility and mental sharpness, aimed at enhancing complex problem solving abilities characterizing dynamic environments. Research-based results involving EEG measurements support optimal cerebral stimulation though use of alpha and beta-1 wave frequencies, comprising a range of 1-20 Hz, enabling the brain to sustain level of prowess up to hours after actual stimulation has ceased. The founders established and proved that through transmission of a variety of waves, among which includes alpha waves, the brain will imitate the waves broadcasted and mirrored upon it. Upon acknowledgment of this refined concept, the Company decided on development of a variety of different BRAIN devices for treatment and healing of several health problems. At the same time, the company had begun a series of rigorous and in-depth examinations which has led to the formal submission of a patent application in the USA. The company is planning to introduce the technology into the wellness market, to address increase the relaxation stage and improve on concentration, the devices will be emitting a low voltage of around 3Volts and with different frequencies in the range of 1 to 25 Hz.More information is provided at: http://www.alfarhythm.com

Executed the Business Plan, acted as the BD director and raised funds to operate the company. The product is being evaluated clinically before the marketing launch.

Magnetecs Corporation designs and manufactures a unique and highly efficient robotic catheterization control system for minimally invasive surgical procedures, and the advanced specialized tools used in these procedures. The Company believes that its proprietary Catheter Guidance Control and Imaging (CGCI) system will greatly improve the efficacy, safety and cost efficiency of many common minimally invasive surgeries. Magnetecs has established advanced electrophysiology surgical suites for CGCI development and testing at the Company’s headquarters facility in Inglewood, California. For additional information on CGCI and Magnetecs Corporation, please visit the Company’s website at www.magnetecs.com.

Elected to become COB of this TASE corporation, April 16th 2013

Acted as the head of the Bio-Medical investment arm of this investment bank of Migdal Capital Markets. Evaluated bio-medical devices and Pharma companies and provided funding and BD services to the Company's clients.

Involved in the DD of new technologies and start ups, and in hands on operarions responnsabilities in each compay we decide to invest in. Positions from Chairman of the board to active board member.

Acted as Life Science advisor to Investment Banking activities of Migdal Capital MArkets.

Assured the young CEO is managing the company correctly and raised more then $5MM for the company.

Nano-Technology company, developing replacment organs from polymers.

Provided BD advise and brought investors for the company.

Oversaw the activities of its CEO.

Member of the founding group of lecturers who established the Bio-Medical Engineering program at Tel Aviv University. Lectured and guided six students to their graduate degrees in Bio-Medical Engineering.

Founded the Department of bio-Medical Engineering. Built it serve the Hospital medical equipment, with a group of five engineers and 15 technicians. Became the central goverment body for medical devices approvals and testing. Acted as advisor to the Menistry of Health on Medical Technologies. Senior Lecturer at Tel Aviv University and one of the founders of the Bio-Medical Engineering program. Guided as mentor to M.Sc and Ph.D students.